Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

The patients who diagnosed with cancer as below - GBM, Colon Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Brain metastases, Lymphoma, Bone Metastatic Cancer , Gastric Cancer, Pancreatic Cancer, Gall bladder Cancer, Prostate Cancer, Kidney Cancer, Bladder cancer, Osteosarcoma, Soft tissue sarcoma, Head and neck cancer, 기타 Brain tumor
The patients who are scheduled for collection such as the patient tissue, pleural fluid, cerebro spinal fluid, blood samples for the purpose of surgery and diagnostics
The patients who agreed and written consent to participate in this research
The patients who diagnosed with cancer as below - GBM, Colon Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Brain metastases, Lymphoma, Bone Metastatic Cancer , Gastric Cancer, Pancreatic Cancer, Gall bladder Cancer, Prostate Cancer, Kidney Cancer, Bladder cancer, Osteosarcoma, Soft tissue sarcoma, Head and neck cancer, 기타 Brain tumor
The patients who are scheduled for collection such as the patient tissue, pleural fluid, cerebro spinal fluid, blood samples for the purpose of surgery and diagnostics
The patients who agreed and written consent to participate in this research

Exclusion Criterias

1) Those who do not agree in writing to participate in research
1) Those who do not agree in writing to participate in research

Summary

Conditions
Refractory Cancer
Design
Time Perspective: Prospective

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Description

■ The specimen obtainer in surgery room contact with the manager of Institute Refractory Cancer Research team by calling to Medi-call system(Phone No.system T.9825). The specimen obtainer gives the information of speciman to the manager . The manager contact to the speciman deleverer and The specima...

■ The specimen obtainer in surgery room contact with the manager of Institute Refractory Cancer Research team by calling to Medi-call system(Phone No.system T.9825). The specimen obtainer gives the information of speciman to the manager . The manager contact to the speciman deleverer and The speciman deleverer transported the specimens safely to the laboratory space. The written informed consent form should obtained from the subject prior to the surgery. In the case of blood samples, The total 15 ~ 20 ㎖ blood (only once) extracted from the subject and about 10 ~ 15 ㎖ blood is used for the genomic DNA extraction.

Inclusion Criterias

The patients who diagnosed with cancer as below - GBM, Colon Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Brain metastases, Lymphoma, Bone Metastatic Cancer , Gastric Cancer, Pancreatic Cancer, Gall bladder Cancer, Prostate Cancer, Kidney Cancer, Bladder cancer, Osteosarcoma, Soft tissue sarcoma, Head and neck cancer, 기타 Brain tumor
The patients who are scheduled for collection such as the patient tissue, pleural fluid, cerebro spinal fluid, blood samples for the purpose of surgery and diagnostics
The patients who agreed and written consent to participate in this research
The patients who diagnosed with cancer as below - GBM, Colon Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Brain metastases, Lymphoma, Bone Metastatic Cancer , Gastric Cancer, Pancreatic Cancer, Gall bladder Cancer, Prostate Cancer, Kidney Cancer, Bladder cancer, Osteosarcoma, Soft tissue sarcoma, Head and neck cancer, 기타 Brain tumor
The patients who are scheduled for collection such as the patient tissue, pleural fluid, cerebro spinal fluid, blood samples for the purpose of surgery and diagnostics
The patients who agreed and written consent to participate in this research

Exclusion Criterias

1) Those who do not agree in writing to participate in research
1) Those who do not agree in writing to participate in research

Locations

Seoul, Gyunggido, 135-710
Seoul, Gyunggido, 135-710

Tracking Information

NCT #
NCT01932047
Collaborators
Not Provided
Investigators
Study Director: Jueun Kim, Coordinator Institutional Refractory Cancer Research